TOP1 and cancer: The reduced levels of Top1 in the CPT-resistant human cancer cells is then expected to disrupt its normal cellular role of preventing the excess level of negative supercoiling at highly transcribed loci and to thereby elevate the accumulation of non-B DNA formation including G4 DNA.